Why Attend?

Last Year’s Agenda
Location & CLE

Join a diverse group of stakeholders – public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others – for this two-day conference on effectively regulating the broad spectrum of tobacco and nicotine products in the US. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.

Call For Proposals

The Call for Proposals will open in late March. Please check back later for more information.

Register by August 13 and SAVE!

Industry & Firms

$1299
  • +$500 for non-members
  • +$100 after 8/13/2020
  • +$100 after 9/17/2020

Non-Profit

$799
  • +$100 for non-members
  • +$100 after 8/13/2020
  • +$100 after 9/17/2020

Government

$799
  • +$100 for non-members
  • +$100 after 8/13/2020
  • +$100 after 9/17/2020

Academic

$799
  • +$100 for non-members
  • +$100 after 8/13/2020
  • +$100 after 9/17/2020

Student

$149
  • students registration
  • full-time students only
  • transcripts required
REGISTER NOW

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

Gold Sponsor

Planning Committee

Issa Abuaita, Al Fakher USA
Scott D. Ballin, Public Health Consultant
James Baumberger, American Academy of Pediatrics
Aruni Bhatnagar, American Heart Association
Tara Lin Couch, EAS Consulting Group, LLC
Michael Cummings, Medical University of South Carolina
Brittani Cushman, Turning Point Brands, Inc.
Stacey Younger Gagosian*, Truth Iniative
Thomas Glynn, Stanford University School of Medicine
Robyn Gougelet, Pinney Associates, Inc.
Ben Haas, Latham & Watkins LLP
Bryan M. Haynes, Troutman Sanders LLP
Dennis Henigan, Campaign for Tobacco-Free Kids
Desmond Jenson, Public Health Law Center – Tobacco Control Legal Consortium
Eshael Johnson, CTP, FDA
Ondrej Koumal, Philip Morris International
Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
Joe Murillo, JUUL Labs
John Marshall, Altria Client Services LLC
Kelley Coleman Nduom, CDER, FDA
Henry Roemer, Specialty Tobacco Council, Inc
Barry Schaevitz, Fox Rothschild LLP
Jim M. Solyst, Swedish Match North America
Mark J. Vaders, Womble Bond Dickinson (US) LLP